M7T.AX - Mach7 Technologies Limited
| Previous close | 0.5450 |
| Open | 0.5450 |
| Bid | 0.5500 x 226200 |
| Ask | 0.5700 x 912100 |
| Day's range | 0.5450 - 0.5700 |
| 52-week range | 0.4450 - 0.8000 |
| Volume | |
| Avg. volume | 105,624 |
| Market cap | 136.623M |
| Beta (5Y monthly) | 1.41 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.0200 |
| Earnings date | 28 Aug 2023 - 01 Sept 2023 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 1.32 |
Simply Wall St.Mach7 Technologies Limited's (ASX:M7T) Intrinsic Value Is Potentially 52% Above Its Share Price
Key Insights The projected fair value for Mach7 Technologies is AU$0.80 based on 2 Stage Free Cash Flow to Equity Mach7...
- Simply Wall St.
Mach7 Technologies Limited's (ASX:M7T) Popularity With Investors Is Under Threat From Overpricing
With a median price-to-sales (or "P/S") ratio of close to 5.2x in the Healthcare Services industry in Australia, you...
- Simply Wall St.
Mach7 Technologies (ASX:M7T) Is In A Strong Position To Grow Its Business
Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...
- Simply Wall St.
Why Mach7 Technologies Limited (ASX:M7T) Could Be Worth Watching
Mach7 Technologies Limited ( ASX:M7T ), is not the largest company out there, but it saw significant share price...
- Simply Wall St.
Mach7 Technologies First Half 2023 Earnings: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2022)
Mach7 Technologies ( ASX:M7T ) First Half 2023 Results Key Financial Results Revenue: AU$16.5m (up 15% from 1H 2022...
- Simply Wall St.
Mach7 Technologies Limited (ASX:M7T) is definitely on the radar of institutional investors who own 50% of the company
Key Insights Given the large stake in the stock by institutions, Mach7 Technologies' stock price might be vulnerable to...
PR NewswireMach7 Technologies recognized as a top performer in the 2023 Best in KLAS Report
Mach7 Technologies, a company specializing in innovative medical imaging and data management solutions for healthcare providers, was identified in the Best in KLAS 2023 Software & Services Report as a 'top performer' by being rated as one of the top three vendors in overall performance for the Universal Viewer segment. Mach7 achieved an overall #2 position in the Universal Viewer market segment, which is part of the Imaging Systems category.
- Simply Wall St.
Mach7 Technologies (ASX:M7T) delivers shareholders stellar 23% CAGR over 5 years, surging 18% in the last week alone
When you buy a stock there is always a possibility that it could drop 100%. But when you pick a company that is really...
- PR Newswire
Mach7 Technologies and Nuvodia Partner to Deliver Industry Differentiated Healthcare Informatics Solutions
Mach7 Technologies, a company specializing in innovative medical imaging and data management solutions for healthcare providers, today announced a partnership with Nuvodia, a technology services organization that creates, manages, secures and supports mission-critical IT environments.
- Simply Wall St.
Mach7 Technologies Limited's (ASX:M7T) Intrinsic Value Is Potentially 86% Above Its Share Price
How far off is Mach7 Technologies Limited ( ASX:M7T ) from its intrinsic value? Using the most recent financial data...
- Simply Wall St.
With 54% ownership, Mach7 Technologies Limited (ASX:M7T) boasts of strong institutional backing
A look at the shareholders of Mach7 Technologies Limited ( ASX:M7T ) can tell us which group is most powerful. With 54...
- Simply Wall St.
Mach7 Technologies (ASX:M7T) shareholders have earned a 25% CAGR over the last five years
It hasn't been the best quarter for Mach7 Technologies Limited ( ASX:M7T ) shareholders, since the share price has...
- Simply Wall St.
Is Now The Time To Look At Buying Mach7 Technologies Limited (ASX:M7T)?
Mach7 Technologies Limited ( ASX:M7T ), is not the largest company out there, but it saw a double-digit share price...